Biologicals

Thiomersal

Thiomersal WHO Consultation on the impact of thiomersal on quality, safety & efficacy of vaccines: regulatory perspectives

Geneva, 15-16 April 2002

ESSENTIAL MEDICINES AND HEALTH PRODUCTS



NEW PUBLICATIONS

UPCOMING EVENTS


Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971